SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-001823
Filing Date
2019-02-04
Accepted
2019-02-04 17:08:58
Documents
2
Period of Report
2019-02-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 2019 BONUS PROGRAM snss-8k_20190201.htm 8-K 49034
2 EX-10.1 2019 BONUS PROGRAM snss-ex101_6.htm EX-10.1 31396
  Complete submission text file 0001564590-19-001823.txt   81807
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 19564816
SIC: 2834 Pharmaceutical Preparations